Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
CHA University
CHA University
CHA University
Peking University
H. Lee Moffitt Cancer Center and Research Institute
Aarhus University Hospital
University of Texas Southwestern Medical Center
UNICANCER
Cedars-Sinai Medical Center
Case Comprehensive Cancer Center